Table 3.

Model 2 random intercept and country-level covariates

	CASP		EURO-Dr		SHr
	OR (95%CI)	ICC	OR (95%CI)	ICC	OR (95%CI)	ICC
THE (% of GDP)	1.16* (1.03–1.30)	0.09	1.28** (1.09–1.49)	0.15	1.27** (1.09–1.48)	0.15
GHE (% of GDP)	1.21*** (1.08–1.36)	0.07	1.31*** (1.11–1.53)	0.14	1.30** (1.11–1.52)	0.14
Country programs—Regional	3.43** (1.54–7.65)	0.07	7.12*** (2.85–17.79)	0.10	6.99*** (2.85–17.11)	0.10
Country programs—Organized	3.12*** (1.69–5.72)	0.07	5.92*** (3.06–11.45)	0.10	5.88*** (3.08–11.22)	0.10

Total health expenditure as a proportion of GDP (THE), government health expenditure as a proportion of GDP (GHE) and Country breast cancer screening program strategy (Country programs: Opportunistic (Base), Regional, Organized). For each of the exposure models the left columns show Odds Ratios and 95% Confidence Intervals for each of the regression models. The right columns show the adjusted intraclass correlation (ICC) of each of the regression models. All models were adjusted for individual-level covariates and exposure variables CASP, EURO-Dr, and SHr. For the full models see Supplementary Table 5

^*p < 0.05

^**p < 0.01

^***p < 0.001